Advertisement

Topics

AstraZeneca Plc Company Profile

11:13 EDT 19th September 2017 | BioPortfolio


News Articles [781 Associated News Articles listed on BioPortfolio]

#jobs #lifescience AstraZeneca – Cambridge: GES Supplier Manager – AstraZeneca Sweden, UK or US

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: GES Supplier Manager – AstraZeneca Swede...

#jobs #lifescience AstraZeneca – Cambridge: Quality Control Analytical BioChemist, AstraZeneca Biologics

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Quality Control Analytical BioChemist, AstraZe...

AstraZeneca Posting Strong Gain On Positive Drug Trial Results

LONDON (dpa-AFX) - After moving sharply higher early in the session, shares of AstraZeneca (AZN) have given back some ground but remain firmly positive in afternoon trading on Friday. AstraZeneca ...

AstraZeneca, Recordati Enter Deal For Seloken; AstraZeneca To Receive $300 Mln

LONDON (dpa-AFX) - AstraZeneca plc (AZN.L, AZN) announced it has entered into an agreement with Recordati for the commercial rights to Seloken/Seloken ZOK and associated Logimax fixed-dose combina...

AstraZeneca 2Q: Soriot's In It For The Long Haul

AstraZeneca's CEO used the company's second-quarter earnings call to proclaim his commitment to the business just weeks after rumors spread...   

Champions Oncology, AstraZeneca collaborate

Champions Oncology, a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, announced a strategic collabor...

AstraZeneca Pays Orexo $2.5M on Taking Respiratory Diseases Program into Phase I

Swedish firm Orexo received a $2.5 million milestone payment from AstraZeneca, relating to the latter’s initiation of Phase I clinical development with the leukotriene (LT) C4 synthase inhibitor pro...

AstraZeneca Misses Endpoint in Big Checkpoint Inhibitor Combo Trial

AstraZeneca has announced its Phase III trial with durvalumab and tremelimumab has failed to achieve better results than standard chemotherapy in lung cancer.  AstraZeneca’s MYSTIC study was ev...

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Rhinocort aqua [AstraZeneca LP]

These highlights do not include all the information needed to use RHINOCORT AQUA Nasal Spray safely and effectively. See full prescribing information for RHINOCORT AQUA Nasal Spray. RHINOCORT AQUA 32 ...

Lexxel®(enalapril maleate-felodipine er)tablets [AstraZeneca LP]

LEXXEL®(enalapril maleate-felodipine ER)TABLETS

Metoprolol succinate [Major Pharmaceuticals]

These highlights do not include all the information needed to use metoprolol succinate extended-release tablets safely and effectively. See full prescribing information for metoprolol succinate extend...

Tamoxifen citrate tablets, usp [Andrx Pharmaceuticals, Inc.]

TAMOXIFEN CITRATE TABLETS, USP

First bxn mouthwash [CutisPharma, Inc]

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Letter--Prudent Formulary Management or Underutilization of the Novel P2Y12 Receptor Inhibitors in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention?

The author is a former employee of AstraZeneca and owns stock in AstraZeneca. The author reports no conflicts of interest related to the subject of this letter.

Efficacy and safety of osimertinib in a Japanese compassionate use program.

Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that targets the T790M mutation of EGFR. In 2016, AstraZeneca conducted a compassionate use pr...

High-throughput flow cytometry for drug discovery: principles, applications, and case studies.

Flow cytometry is a technology providing multiparametric analysis of single cells or other suspension particles. High-throughput (HT) flow cytometry has become an attractive screening platform for dru...

Preparative Scale Resolution of Enantiomers Enables Accelerated Drug Discovery and Development.

The provision of pure enantiomers is of increasing importance not only for the pharmaceutical industry but also for agro-chemistry and biotechnology. In drug discovery and development, the enantiomers...

Cell scientist to watch - Paul Timpson.

Paul Timpson received his bachelor's degree from the University of Strathclyde, UK and completed his PhD under the supervision of Margaret Frame at the Beatson Institute for Cancer Research and the Un...

Clinical Trials [37 Associated Clinical Trials listed on BioPortfolio]

Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis

This study is to evaluate non inferiority of Eurofarma budesonide nasal spary x referral Astrazeneca budesonide. Half patients will receive Eurofarma medication and half patients will rece...

Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition.

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions

Subjects to compare the single dose bioavailability of Torrent's Esomeprazole Magnesium DR Capsules 40 mg and Nexium® 40 mg DR Capsules of AstraZeneca LP, USA. Dosing periods of studies w...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis

This study is to evaluate non inferiority of Eurofarma budesonide nasal spray x referral Astrazeneca budesonide. Half patients will receive Eurofarma medication and half patients will rece...

Companies [67 Associated Companies listed on BioPortfolio]

AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a leader in gastrointestin...

AstraZeneca Pharmaceuticals LP

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a lead...

AstraZeneca and The Medicines Company

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastro...

AstraZeneca HealthCare Foundation

Established in 1993, the AstraZeneca HealthCare Foundation is a Delaware not-for-profit corporation and a 501(c)(3) entity organized for charitable purposes including to promote p...

AstraZeneca AS

AstraZeneca er et av verdens ledende farmasøytiske selskaper. Vi bruker hvert år ca. 25 milliarder norske kroner på forskning verden over for å utvikle nye medisiner. Dette har resultert i en rekk...

More Information about "AstraZeneca Plc" on BioPortfolio

We have published hundreds of AstraZeneca Plc news stories on BioPortfolio along with dozens of AstraZeneca Plc Clinical Trials and PubMed Articles about AstraZeneca Plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AstraZeneca Plc Companies in our database. You can also find out about relevant AstraZeneca Plc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record